A promising alternative involves the use of nanoparticles capable of delivering therapeutic agents directly to the tumor.
The researchers created a tool to predict which patients will respond to this therapy based on this therapy that shows the importance of metabolism in the tumor microenvironment.
Weizmann Institute researchers have applied for a patent and seek commercialization
DNA methylation sheds light on varieties of the most common and most fatal primary brain cancer.
Hadassah-University Medical Center and a pharmaceutical company offer personalized cancer care based on genomic profiling.
A father of four became convinced that his loyal wife was being unfaithful. Here's what was really going on
“Watch and wait” describes the limbo that sufferers of a chronic cancer like mine must navigate. You only treat when the tumors get large enough or you notice unpleasant “B” symptoms.
An AI tool based on a new concept called “meta-synergy” helps find more powerful drug combinations.
Israel's Sheba Medical Center initiated and is funding a program to transport Afghan children with the disease into Pakistan for treatment.
JPOST Digital Library
